417
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics

, , , , , , , , , , & show all
Pages 1687-1699 | Accepted 12 Mar 2014, Published online: 07 Apr 2014

References

  • Centers for Disease Control and Prevention. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children – United States, 2003 and 2007. Morb Mortal Wkly Rep 2010;59:1439-43
  • Froehlich TE, Lanphear BP, Epstein JN, et al. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007;161:857-64
  • Visser S, Lesesne C, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics 2007;119(Suppl 1):S99-106
  • Lara C, Fayyad J, de Graaf R, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry 2009;65:46-54
  • American Academy of Pediatrics. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128(5):1007-22
  • Pelham WE Jr, Fabiano GA. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychology 2008;37:184-214
  • Zima BT, Bussing R, Tang L, et al. Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program. J Am Acad Child Adolesc Psychiatry 2010;49:1225-37, 37 e1-11
  • Zima BT, Hurlburt MS, Knapp P, et al. Quality of publicly-funded outpatient specialty mental health care for common childhood psychiatric disorders in California. J Am Acad Child Adolesc Psychiatry 2005;44:130-44
  • Adler L, Nierenberg A. Review of medication adherence in children and adults with ADHD. Postgrad Med 2010;122:184-91
  • Charach A, Fernandez R. Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatry Rep 2013;15:1-8
  • Miller AR, Lalonde CE, McGrail KM, Armstrong RW. Prescription of methylphenidate to children and youth, 1990–1996. Can Med Assoc J 2001;165:1489-94
  • Gau SS, Shen HY, Chou MC, et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 2006;16:286-97
  • Palli SR, Kamble PS, Chen H, Aparasu RR. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2012;22:139-48
  • Zima BT, Murphy JM, Scholle SH, et al. National quality measures for child mental health care: background, progress, and next steps. Pediatrics 2013;131(Suppl 1):S38-49
  • National Committee for Quality Assurance. 2012 Accreditation Benchmarks and Thresholds. 2012. Available at: http://www.ncqa.org/portals/0/PolicyUpdates/Trending%20and%20Benchmarks/2012%20BENCHMARKS%20AND%20THRESHOLDS_FINAL-UpdatedFeb2012[1]_2.3.12.pdf [Last accessed 7 July 2013]
  • National Committee for Quality Assurance. Follow-Up Care for Children Prescribed ADHD Medication. 2009. Available at: http://www.ncqa.org/portals/0/Follow-Up%20Care%20for%20Children%20Prescribed%20ADHD%20Medication.pdf [Last accessed 15 July 2013]
  • Zima BT, Mangione-Smith R. Gaps in quality measures for child mental health care: an opportunity for a collaborative agenda. J Am Acad Child Adolesc Psychiatry 2011;50:735-7
  • National Quality Forum. Measure Evaluation Criteria. 2012. Available at: http://www.qualityforum.org/Measuring_Performance/Submitting_Standards/Measure_Evaluation_Criteria.aspx [Last accessed 7 July 2013]
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994
  • American Hospital Formulary Service. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists Inc., 2013
  • Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-6
  • Guevara J, Lozano P, Wickizer T, et al. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder. Pediatrics 2002;109:733-9
  • Chen CY, Gerhard T, Winterstein AG. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009;19:187-95
  • Barner JC, Khoza S, Oladapo A. ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Curr Med Res Opin 2011;27(Suppl 2):13-22
  • Christensen L, Sasane R, Hodgkins P, et al. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 2010;26:977-89
  • Hodgkins P, Sasane R, Christensen L, et al. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr Med Res Opin 2011;27(Suppl 2):53-62
  • Lawson KA, Johnsrud M, Hodgkins P, et al. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther 2012;34:944-56
  • Bussing R, Koro-Ljungberg M, Noguchi K, et al. Willingness to use ADHD treatments: a mixed methods study of perceptions by adolescents, parents, health professionals and teachers. Soc Sci Med 2012;74:92-100
  • Rothenberger A, Dopfner M. Editorial: observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence. Eur Child Adolesc Psychiatry 2011;20(Suppl 2):S235-42
  • van den Ban E, Souverein C, Swaab H, et al. Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. Attention Deficit Hyperactivity Disord 2010;2:213-20
  • Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2003;160:1071-7
  • Atzori P, Usala T, Carucci S, et al. Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study. J Child Adolesc Psychopharmacol 2009;19:673-81
  • Toomey SL, Sox CM, Rusinak D, Finkelstein JA. Why do children with ADHD discontinue their medication? Clin Ped 2012;51:763-9
  • Co JP, Johnson SA, Poon EG, et al. Electronic health record decision support and quality of care for children with ADHD. Pediatrics 2010;126:239-46
  • Epstein JN, Langberg JM, Lichtenstein PK, et al. Use of an Internet portal to improve community-based pediatric ADHD care: a cluster randomized trial. Pediatrics 2011;128:1201-8
  • McCarthy S, Asherson P, Coghill D, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009;194:273-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.